"Kaprelsa", 300 mg, (vandetanib) analogues kumukuai. Where e kūʻai "Kaprelsa" ho'ēmi?

Ke Kula Kaiapuni 'ano i hoʻohana lāʻau waiū, akā, i waena o ka antitumor konohiki, nō hoʻi ka "Kaprelsa" papa (300 mg) ma lalo o diagnosed thyroid Ka maʻi' aʻai - he lāʻau hiki no pōkole wā o ka manawa, e 'ūlōlohi i ka ulu ana o malignant neoplasms ma kekahi kahua o ko lākou ulu.

E like me ka noiʻi, ka haku mele "Kaprelsa" o ka mea 'O ke kaulike i loko o ka helu, a me ka hū hapa iki o ka eiiiiiaiou. Kēia maximizes ka Loaʻaʻia, e hoike i ka hana waiwai ka ho'āʻana i ka laulā o ka ho'ākāka 'ia ma hoomalolo - vandetaniba. Ua inhibits ke kahua o na moku koko ana i kaʻeho, 'aʻole hoʻi kona ulu a me ka ulu ana o metastases, e leie aku ke kaōhiʻana pathological keʻano o ka hanaʻana o kekahi oolea.

Where hiki lāʻau "Kaprelsa" kūʻai ho'ēmi

I hiki ke ike mai i ka luna i oleloia huaale i ka mea paahana maikai loa i hiki ke hooki i ka hooulu ana o ka mea pepehi maʻi. Akā, i ka lilo ana o ka lāʻau mea kiʻekiʻe nui iho la ia.

I Moscow, no ka mea hoike, i ka lāʻau "Kaprelsa" (300 mg) Price E hoʻopaʻa i loko o 300 000 hamo i., Ka mea hana e problematic no ke kuai ana o na mea he nui nā mea maʻi. Ma ia mau hoopii, e hiki noi no kōkua ma ka paena, a i ka maopopo Track moolelo, - WWW.ONKO24.COM. Eia oe e ke kaumaha nui kaulana nōhie ai 'no ka iapaau ana o ka maʻi' aʻai.

Lakou i ua hanaʻia ma lalo o ka laikini ma Inia, a i ka ia haku mele 'ana, a ma keia hope aku i ka ia laulā me ka hao-inoa ai'. Akā, mahope mai o ko lakou mau Manufacturers i pono, e pana aku au i ke kālā ma ka hoʻolaha 'ole' ana, a laila, ua nui oi affordable i ka waiwai o ia mau waiwai. Ma keia kumu, kaa ma kekahi nōhie "Kaprelsa" kumukuai - kēia mea,ʻaʻole i kaʻilihune i kona haʻahaʻa ka hoʻokōʻana.

Hiʻona o ka palapala noi

Nō kāu, he ahonui ua lawelawe i loko o ka hookahi kela la i keia papa - 300 mg. Vandetanib lawe,ʻaʻole correlating me ka hoʻohana 'ana o ka palaoa manawa, akā, i kekahi manawa.

Inā pono, ke papa hiki ole pulverizing, ua hoʻopau i ole-carbonated wai (50 mg). A inu i ka kūpono wehe e refill hou ka wai aniani a me ka holoi ana o ka pā, e inu i koe lāʻau e hōʻalo ai i ka hoemi i ka laulā vandetaniba hana.

Contraindications

E ho ohana ana o ka lāʻau "Kaprelsa" (vandetanib) ua i haawiia'ku ai i nā mea maʻi ua loaʻaʻa puʻuwai a hepatic insufficiency, e loaa ana huʻi hoʻoʻino maʻi, lesions o ka digestive'āpana, hapai, lactating, e hoomanawanui i poe kahiko 18 makahiki, a ua i ka welelau o ke allergic reactions.

ʻaoʻao 'ole o ka lāʻau

Mawaena o ka adverse ole ana ka loaa ana "Kaprelsa" papa (300 mg) no ka hahai symptoms i ka loa, he pono ole.

• mahuahua ma ka MH;
• abdominal eha, diarrhea ulu ana;
• nausea;
• luhi;
• haanou ana;
• asthenia;
• kāna hana no nā mea'ōnaehana mānowai koko oihana;
• hypocalcemia;
• kahe o ka ikaika loa ka makemake;
• hiamoe kāna hana;
• ili reactions (me dermatitis, malooʻili, huehue, maneo);
• kui nā mea palahēhē;
• corneal opacity a me nā mall loli ma laila;
• headache paha pōniuniu;
• ulu o ka bronchitis, e like me kekahi keena naehana nā mea palahēhē a urinary'āpana.

Akā, i loko o keia hihia, ma ka pane, vandetanib i ke kiekie o ka hoʻokōʻana a hiki i ka immunocompromised nā mea maʻi, a ma ka poe e loaa ana mai adverse ana.